Richard Dekhuijzen - Concepedia

Author

Richard Dekhuijzen

Also Known As

Dekhuijzen R, R Dekhuijzen, R. Dekhuijzen, Richard Dekhuijzen, Richard P.N. Dekhuijzen, Richard PN Dekhuijzen, Ulrich Costabel

108

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Royal Brompton Hospital University of Aberdeen University Medical Center Groningen

About

Richard Dekhuijzen is an author at Radboud University Nijmegen specializing in medicine, pulmonary medicine, and pulmonary disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.1K
2	Health Sciences	5	5	506
3	Allergy	2	2	51
4	Natural Sciences	1	1	110
5	Public Health	1	1	73

Richard Dekhuijzen

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis Maurits Demedts, Jürgen Behr, Roland Buhl, New England Journal of Medicine	2005	972
Skeletal muscle dysfunction in chronic obstructive pulmonary disease: A statement of the American Thoracic Society and European Respiratory Society Richard Casaburi, Rik Gosselink, Marc Decramer, American Journal of Respiratory and Critical Care Medicine Advanced Lung DiseasePhysiologyPulmonary PhysiologyPulmonary FibrosisApplied Physiology	1999	324
Diaphragm adaptations in patients with COPD Coen A. C. Ottenheijm, Leo Heunks, Richard Dekhuijzen Respiratory Research	2008	149
Mindfulness‐based stress reduction added to care as usual for lung cancer patients and/or their partners: A multicentre randomized controlled trial Melanie P. J. Schellekens, Desiree G. M. van den Hurk, Judith B. Prins, Psycho-Oncology	2017	134
Region of Difference 1 in Nontuberculous <i>Mycobacterium</i> Species Adds a Phylogenetic and Taxonomical Character Jakko van Ingen, Rina de Zwaan, Richard Dekhuijzen, Journal of Bacteriology Pathogenic MicrobiologyBacteriologyMicrobial EvolutionPhylogenetic AnalysisMedical Microbiology	2009	110
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands Jakko van Ingen, Tridia van der Laan, Richard Dekhuijzen, International Journal of Antimicrobial Agents Pulmonary TuberculosisAntimicrobial SusceptibilityHealth SciencesVitro Drug SusceptibilityTuberculosis	2009	104
“Can do” versus “do do”: A Novel Concept to Better Understand Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Hieronymus W. van Hees, Rob C. van Lummel, Richard Dekhuijzen, Journal of Clinical Medicine	2019	75
<i>Mycobacterium xenopi</i>Clinical Relevance and Determinants, the Netherlands Jakko van Ingen, Martin J. Boeree, Wiel C.M. de Lange, Emerging infectious diseases Medical MicrobiologyPulmonary TuberculosisMycobacterium XenopiPathogenic MicrobiologyDiagnostic Criteria	2008	73
Clinical relevance of Mycobacterium chelonae–abscessus group isolation in 95 patients Jakko van Ingen, Rina de Zwaan, Richard Dekhuijzen, Journal of Infection Medical MicrobiologyAntimicrobial SusceptibilityMicrobial DiseaseClinical RelevanceMicrobiology	2009	71
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis Tjard Schermer, Niels H. Chavannes, Richard Dekhuijzen, Respiratory Medicine AsthmaPulmonary CareAdvanced Lung DiseaseRespiratory DiseasesChronic Bronchitis	2009	70

Page 1